Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Takashi Komatsu, MD"'
Autor:
Mahito Ozawa, MD, Takashi Komatsu, MD, Yoshihiro Sato, MD, Fusanori Kunugita, MD, Hideaki Tachibana, MD, Atsushi Tashiro, MD, Hitoshi Okabayashi, MD, Motoyuki Nakamura, MD,PhD
Publikováno v:
Journal of Arrhythmia, Vol 31, Iss 5, Pp 302-306 (2015)
Background: Approximately one-third of the patients undergoing cardiovascular surgery reportedly experience paroxysmal atrial fibrillation (AF) during the postoperative period. However, the usefulness of antiarrhythmic drugs for preventing postoperat
Externí odkaz:
https://doaj.org/article/07efbe059a2344fdbedf254b62d58250
Autor:
Mahito Ozawa, MD, Takashi Komatsu, MD, Hideaki Tachibana, MD, Yoshihiro Sato, MD, Makoto Orii, MD, Fusanori Kunugita, MD, Motoyuki Nakamura, MD
Publikováno v:
Journal of Arrhythmia, Vol 25, Iss 2, Pp 81-88 (2009)
Aim and method: There have been few reports about the risk of ischemic stroke in elderly patients with non-valvular paroxysmal atrial fibrillation (NVPAF). The aim of this study was to evaluate the validity of the guidelines issued by the Japanese Ci
Externí odkaz:
https://doaj.org/article/521a09636da14659814af38e546fa4ab
Autor:
Takashi Komatsu, MD, Hideaki Tachibana, MD, Yoshihiro Sato, MD, Mahito Ozawa, MD, Kyoko Ohshima, MD, Motoyuki Nakamura, MD, Daisuke Horiuchi, MD, Takao Kobayashi, MD, Ken Okumura, MD
Publikováno v:
Journal of Arrhythmia, Vol 23, Iss 2, Pp 124-130 (2007)
Objective: To investigate the long-term effects of combination therapy with antiarrhythmic agents and pravastatin (10 mg/day) in maintaining sinus rhythm in patients with paroxysmal atrial fibrillation (AF) and hyperlipidemia. Method and Results: In
Externí odkaz:
https://doaj.org/article/aeb9fa40075141a38a0d1ced3f2d131c
Autor:
Takashi Komatsu, MD, Yoshihiro Satou, MD, Hideaki Tachibana, MD, Motoyuki Nakamura, MD, Ken Okumura, MD, Shin Nakamura, MD, Osamu Suzuki, MD, Daisuke Horiuchi, MD, Kunihiko Yomogida, MD
Publikováno v:
Journal of Arrhythmia, Vol 22, Iss 1, Pp 37-43 (2006)
This study sought to evaluate the efficacy of long-term flecainide therapy in maintaining sinus rhythms in patients with paroxysmal atrial fibrillation (AF. based on time of onset. Flecainide (150 mg/day. was administered as an antiarrhythmic drug to
Externí odkaz:
https://doaj.org/article/ed0c7da6c816431d97f4cb14decdb25b